Protected: The evolving ovarian cancer treatment algorithm: What’s new for your patients in 2022?
This content is password-protected. To view it, please enter the password below. Password:
Author GSK
Trending
- Microplastics in intravenous infusions: emerging health concerns for medical practitioners
- Interval breast cancer: understanding risks and the need for enhanced screening
- Prostate cancer and erectile function: NeuroSAFE technique enhances postoperative outcomes in robot-assisted radical prostatectomy
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- ASCO 2026: Selpercatinib shows decrease in risk of disease recurrence or death as adjuvant therapy for early-stage RET fusion-positive NSCLC
- ASCO 2026: Digital symptom monitoring with nurse support helps maintain quality of life in advanced cancer
- ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
- ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
- ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
- ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
- ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
- ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
